-
1
-
2
Intermediate-dose immune tolerance induction outperforms with faster success, less bleeding, and no added cost in comparison with low dose: a multicenter randomized clinical trial
Published 2025-01-01Subjects: “…immune tolerance induction…”
Get full text
Article